Theravance Biopharma, Inc. (TBPH)

CIK 1583107 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Theravance Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Oct 5, 202615-12G0001104659-26-113695
Sep 28, 202640001357550-26-000033
Sep 25, 2026SCHEDULE 13D/A0001193125-26-402801
Sep 24, 202640001589602-26-000005
Sep 24, 202640001833453-26-000009
Sep 24, 202640001625377-26-000007
Sep 24, 202640001270734-26-000007
Sep 24, 202640001898490-26-000017
Sep 24, 2026S-8 POS0001104659-26-110405
Sep 24, 202640002012524-26-000011
Sep 24, 2026S-8 POS0001104659-26-110398
Sep 24, 2026S-8 POS0001104659-26-110411
Sep 24, 2026S-8 POS0001104659-26-110404
Sep 24, 2026S-8 POS0001104659-26-110400
Sep 24, 2026S-8 POS0001104659-26-110410
Sep 24, 2026S-8 POS0001104659-26-110402
Sep 24, 2026S-8 POS0001104659-26-110403
Sep 24, 202640001961289-26-000011
Sep 24, 2026S-8 POS0001104659-26-110399
Sep 24, 2026S-8 POS0001104659-26-110407
Sep 24, 202640001302443-26-000018
Sep 24, 202640001199297-26-000006
Sep 24, 202640001966698-26-000011
Sep 23, 202625-NSE0001354457-26-000901
Sep 23, 20268-K0001104659-26-109979